Cargando...
How Does an Anti-CTLA4 Antibody Promote Cancer Immunity?
Anti-CTLA-4 antibodies can induce lasting protection for some melanoma patients. However, their therapeutic potential is limited by significant immunotherapy-related adverse effects (irAE). Here, we argue that the therapeutic effect may be based on an agonist activity that is fundamentally distinct,...
Gardado en:
| Publicado en: | Trends Immunol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6589807/ https://ncbi.nlm.nih.gov/pubmed/30497614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2018.10.009 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|